Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Aytu Biopharma's Return on Capital Employed [ROCE] was -15.49% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 2.68 percentage points from -12.80% a year earlier but up 11.17 percentage points from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Return on Capital Employed [ROCE] at Aytu Biopharma came in at -13.87%, down 0.40 percentage points from FY2025.

  • Return on Capital Employed [ROCE] shows a five-year change of +44.97 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Capital Employed [ROCE] was -13.48% in FY2025 (-11.03 pp), -2.45% in FY2024 (+22.64 pp), -25.09% in FY2023 (+55.02 pp) and -80.10% in FY2022 (-21.26 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -123.17% (fiscal Q4 2022) and 1.84% (fiscal Q3 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for seven straight quarters, with an average year-over-year change of -4.80 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q4 2023 (a gain of 99.74 percentage points); the worst was fiscal Q4 2022 (a drop of 86.19 percentage points).
  • Per Business Quant data, AYTU's Return on Capital Employed [ROCE] in the three fiscal quarters before Q4 2026 was -26.66% (Q3 2026), -14.98% (Q2 2026) and -14.34% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.52%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 21.60%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.33%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.91%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 17.37%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.15%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 11.32%
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn -15.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.49%
Mar 31, 2026 -26.66%
Dec 31, 2025 -14.98%
Sep 30, 2025 -14.34%
Jun 30, 2025 -12.80%
Mar 31, 2025 -5.00%
Dec 31, 2024 -12.49%
Sep 30, 2024 -2.97%
Jun 30, 2024 -2.60%
Mar 31, 2024 1.84%
Dec 31, 2023 -9.00%
Sep 30, 2023 -23.30%
Jun 30, 2023 -23.43%
Mar 31, 2023 -58.01%
Dec 31, 2022 -100.60%
Sep 30, 2022 -118.21%
Jun 30, 2022 -123.17%
Mar 31, 2022 -100.45%
Dec 31, 2021 -70.87%
Sep 30, 2021 -55.82%
API Access

Aytu Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY